Detalhe da pesquisa
1.
Initial surveillance in men with marker negative clinical stage IIA non-seminomatous germ cell tumours.
BJU Int
; 133(6): 717-724, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38293778
2.
Risk and mortality of testicular cancer in patients with neurodevelopmental or other psychiatric disorders.
Br J Cancer
; 128(12): 2261-2269, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37088800
3.
Validation of a prediction model for post-chemotherapy fibrosis in nonseminoma patients.
BJU Int
; 132(3): 329-336, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37129962
4.
Prevalence and predictors for fertility-related distress among 1010 young adults 1.5 years following cancer diagnosis - results from the population-based Fex-Can Cohort study.
Acta Oncol
; 62(12): 1599-1606, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37909865
5.
Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial.
Lancet Oncol
; 23(3): 362-373, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35131040
6.
Low-grade inflammation in survivors of childhood cancer and testicular cancer and its association with hypogonadism and metabolic risk factors.
BMC Cancer
; 22(1): 157, 2022 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35135482
7.
The prognostic significance of lactate dehydrogenase levels in seminoma patients with advanced disease: an analysis by the Global Germ Cell Tumor Collaborative Group (G3).
World J Urol
; 39(9): 3407-3414, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33683412
8.
Fertility-related information received by young women and men with cancer - a population-based survey.
Acta Oncol
; 60(8): 976-983, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33764839
9.
Cancer therapy and risk of congenital malformations in children fathered by men treated for testicular germ-cell cancer: A nationwide register study.
PLoS Med
; 16(6): e1002816, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31163029
10.
Prematurity and neonatal outcome including congenital malformations after maternal malignancy within six months prior to or during pregnancy.
Acta Obstet Gynecol Scand
; 96(11): 1357-1364, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28777448
11.
Climbing the ladder of success in testicular cancer.
Acta Oncol
; 60(6): 693-694, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34092174
12.
Characteristics of the Offspring of Women with a History of Malignancy, Excluding Congenital Malformations.
J Obstet Gynaecol Can
; 38(11): 1037-1044, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27969558
13.
Bilateral testicular germ cell tumors in patients treated for clinical stage I non-seminoma within two risk-adapted SWENOTECA protocols.
Acta Oncol
; 54(4): 493-9, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25192551
14.
[Drastic changes in the treatment of metastatic prostate cancer]. / Behandling av metastaserad prostatacancer.
Lakartidningen
; 1212024 Apr 23.
Artigo
em Sueco
| MEDLINE | ID: mdl-38651316
15.
Impact of teratoma on survival probabilities of patients with metastatic non-seminomatous germ cell cancer: Results from the IGCCCG Update Consortium.
Eur J Cancer
; 202: 114042, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38564927
16.
Implementation of the measure of case discussion complexity to guide selection of prostate cancer patients for multidisciplinary team meetings.
Cancer Med
; 12(14): 15149-15158, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37255390
17.
Do young adults with cancer receive information about treatment-related impact on sex life? Results from a population-based study.
Cancer Med
; 12(8): 9893-9901, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36748659
18.
A prospective phase II study of prostate-specific antigen-guided salvage radiotherapy and 68Ga-PSMA-PET for biochemical relapse after radical prostatectomy - The PROPER 1 trial.
Clin Transl Radiat Oncol
; 36: 77-82, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35873652
19.
Unilateral or Bilateral Retroperitoneal Lymph Node Dissection in Nonseminoma Patients with Postchemotherapy Residual Tumour? Results from RETROP, a Population-based Mapping Study by the Swedish Norwegian Testicular Cancer Group.
Eur Urol Oncol
; 5(2): 235-243, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33750683
20.
Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium.
J Clin Oncol
; 39(14): 1563-1574, 2021 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33822655